Check out our news

Get our newsletters

Published on the 11 November 2016

Parkinson 6 OHDA preclinical: New POC on rat to repair neurons, with new compound.

Researchers from the college of Pharmaceutical Sciences in China have recently studied a compound that enhances neuronal recovery in a rat model of Parkinson’s disease (Parkinson 6 OHDA). Parkinson’s…

Science and innovation
Published on the 7 November 2016

Evaluating preclinical emesis induced by PDE4 inhibitors via a noradrenergic pathway

Emesis and/or Nausea are commonly reported side effects associated with several drugs such as 4 phosphodiesterase (PDE4) inhibitors and is a major drawback for the therapeutic use of these drugs. The …

Science and innovation
Published on the 3 November 2016

Join Syncrosome team at Bio-Europe in Cologne, Germany, next week!

Syncrosome invites you to visit us at Bio-Europe, November 7th to November 9th 2016, in Cologne, Germany. Emmanuelle Bettendorf, our Business Developer would be delighted to meet you their and discus…

Events
Published on the 25 October 2016

Join ETAP-Lab at Hi Europe & Ni

Join us at Hi Europe & Ni Hi Europe &Ni promises you a complete 360 degree perspective of the nutrition and health ingredients industry through an exclusive offering of new ingredients & …

Events
Published on the 18 October 2016

Syncrosome at the 2nd DDIP in Hamburg

The 2nd Drug Discovery Innovation Programme will feature 2 days of interactive presentations, poster presentation and networking opportunity, in Hamburg (Germany) from 20 to 21st of October. This conf…

Science and innovation Events
Published on the 11 October 2016

BACK from the 2nd Annual Neuroscience R&D Technologies Conference

Syncrosome, participated last week to the Neuroscience R&D Technologies Conference in London, to present key Parkinson's data. It was 2 very interesting days spent to discuss about the new adva…

Science and innovation
Published on the 5 October 2016

NEW RATING SCALE OF AIMs IN OUR L-DOPA INDUCED DYSKINESIAS RAT MODEL

L-DOPA remains the most effective therapy in the management of the motor symptoms of Parkinson's disease (PD). However, chronic treatment with levodopa is associated with the risk of development of mo…

Science and innovation
Published on the 27 September 2016

Poster presentation at the 4th World Congress on Targeting Microbiota

DERMATOLOGY : ETAP-Lab's preclinical results obtained for PiLeJe will be presented in a poster “Identification of two probiotic strains able to prevent skin inflammation in a murine mo…

Science and innovation Events

Explore our scientific resources and browse posters…

Explore our resources